Pharma giant Sanofi SNY recently announced that it will acquire Blueprint Medicines for a total deal value of up to $9.5 billion to expand its portfolio in rare immunological disease and add an ...

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

The UK Financial Conduct Authority teams up with Nvidia to launch a powerful AI sandbox, giving financial firms access to ...

Oil prices dipped slightly on weak Chinese economic data, but broader market sentiment remains buoyant ahead of crucial ...